Thu Sep 19 05:44:55 UTC 2024: ## SHL Telemedicine Outperforms Concord Medical Services: MarketBeat Analysis

**Tel Aviv, Israel – September 19, 2024** – A recent analysis by MarketBeat News has revealed that SHL Telemedicine (NASDAQ:SHLT) appears to be a more favorable investment than Concord Medical Services (NYSE:CCM), both small-cap medical companies.

The analysis compared the two companies based on valuation, analyst recommendations, profitability, institutional ownership, risk, dividends, and earnings. SHL Telemedicine emerged as the winner in five out of eight categories, demonstrating its potential for stronger long-term growth.

**Key Findings:**

* **Analyst Sentiment:** SHL Telemedicine boasts a consensus price target of $11.00, representing a potential upside of 193.33%. This optimistic outlook from analysts suggests they believe SHL Telemedicine is more likely to deliver significant returns compared to Concord Medical Services.
* **Volatility:** SHL Telemedicine’s share price is significantly less volatile than the S&P 500, with a beta of -0.54. This indicates lower risk for investors.
* **Earnings and Revenue:** SHL Telemedicine boasts higher earnings despite having lower revenue than Concord Medical Services. This highlights the company’s strong profitability.
* **Institutional Ownership:** A substantial 20.1% of SHL Telemedicine shares are held by institutional investors, suggesting confidence in the company’s long-term growth potential.

**Company Background:**

SHL Telemedicine specializes in personal telemedicine solutions, offering devices such as a mobile 12-lead ECG for heart attack detection and remote blood pressure monitoring tools. The company serves a diverse customer base including physicians, hospitals, and insurance funds.

Concord Medical Services, based in China, operates a network of radiotherapy and diagnostic imaging centers. Its services encompass linear accelerators, proton therapy, gamma knife radiosurgery, and various imaging services.

**Conclusion:**

While both companies hold potential within the healthcare sector, SHL Telemedicine appears to be the superior investment choice based on MarketBeat’s comprehensive analysis. Investors seeking a potentially profitable and less volatile investment opportunity may want to consider exploring SHL Telemedicine.

Read More